Sugi Predict

Sugi Predict / Compounds / SCHEMBL2052079

SCHEMBL2052079

SCHEMBL2052079

Oc1cc2ccc3cccc4ccc(c1)c2c34

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.61
▸ CYP1A2 P05177 5/20 0.61
▸ CYP3A4 P08684 4/20 0.61
▸ HSD17B10 Q99714 4/20 0.61
▸ HPGD P15428 4/20 0.61
▸ CYP1A1 P04798 2/20 0.61
▸ CYP1B1 Q16678 2/20 0.61
▸ TSHR P16473 2/20 0.61
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ ERBB2 P04626 1/20 0.48
▸ FYN P06241 1/20 0.48
▸ MAOA P21397 1/20 0.48
▸ ACHE P22303 1/20 0.48
▸ AHR P35869 1/20 0.48
▸ DNMT1 P26358 1/20 0.48
▸ CACNA1B Q00975 1/20 0.48
▸ APBA1 Q02410 1/20 0.48
▸ MCL1 Q07820 1/20 0.48
▸ APOBEC3G Q9HC16 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29530611 1.00 ALDH1A1 (0.61) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
Butane SCHEMBL29227305 0.89 CYP1A2 (0.48) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL124871 0.88 CYP1A2 (0.48) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
Nonane SCHEMBL29227378 0.83 PTGS2 (0.46) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
Pyrene SCHEMBL21357510 0.82 ALDH1A1 (0.69) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL11900061 0.80 NQO2 (0.50) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL25230391 0.80 ABL1 (0.58) CYP1A2CYP3A4ESR1HSD17B1HSD17B2
SCHEMBL40362 0.79 ALDH1A1 (0.73) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL106821 0.79 ALDH1A1 (0.73) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD
SCHEMBL30867671 0.79 ALDH1A1 (0.73) ALDH1A1CYP1A2CYP3A4HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119080587-A Halogenated pyrenyl intermediate, derivative thereof, preparation method and application 广东工业大学 2024-12-06 — — CN claimed
CN-117447333-A Pyrenyl blue light material capable of emitting in narrow band, and preparation method and application thereof 广东工业大学 2024-01-26 — — CN claimed
WO-2023103611-A1 BROMOPYRENE INTERMEDIATE AND DERIVATIVES THEREOF, PREPARATION METHOD, AND USE 广东工业大学 2023-06-15 — — WO claimed
CN-114149307-B Bromopyrene intermediate and derivative, preparation method and application thereof 广东工业大学 2023-04-11 — — CN claimed
CN-114149307-A Bromopyrene intermediate and derivative, preparation method and application thereof 广东工业大学 2022-03-08 — — CN claimed
CN-106967213-A Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance 厦门赛诺邦格生物科技股份有限公司 2017-07-21 — — CN claimed
CN-1535145-A Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors ʵ 2004-10-06 — — CN claimed
CN-117447333-B Pyrenyl blue light material capable of emitting in narrow band, and preparation method and application thereof 广东工业大学 2026-05-12 — — CN disclosed
US-20260098188-A1 RELEASE AGENT COMPOSITION FOR LIGHT IRRADIATION RELEASE, AND ADHESIVE COMPOSITION FOR LIGHT IRRADIATION RELEASE NISSAN CHEMICAL CORPORATION (JP) 2026-04-09 — — US disclosed
US-12572075-B2 Composition, method of forming resist underlayer film, and method of forming resist pattern JSR CORPORATION (JP) 2026-03-10 — — US disclosed
EP-4692944-A1 COMPOSITION FOR FORMING RESIST UNDERLAYER FILM Nissan Chemical Corporation (JP) 2026-02-11 — — EP disclosed
EP-4678708-A1 ADHESIVE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2026-01-14 — — EP disclosed
EP-4678709-A1 ADHESIVE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2026-01-14 — — EP disclosed
CN-1617743-A New pharmaceutical combinations for nos inhibitors PFIZER PROD INC (US) 2005-05-18 — — CN disclosed
CN-1535145-A Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors ʵ 2004-10-06 — — CN disclosed
CN-1303379-A 2-Aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors PFIZER PROD INC (US) 2001-07-11 — — CN disclosed
CN-1268133-A 2-Aminopyridines containing fused ring substituents as NOS inhibitors PFIZER PROD INC (US) 2000-09-27 — — CN disclosed
US-5750139-A CONTAINED IN INNER SPACE BETWEEN IMPERMEABLE TOP LAYER AND MICROPOROUS MEMBRANE WELDED TOGATHER DROSSAPHARM AG (CH) 1998-05-12 — — US disclosed
CN-1113434-A Drug DROSSAPHARM AG (CH) 1995-12-20 — — CN disclosed
US-3931298-A FROM A HYDROXYAROMATIC AND AMMONIA, GROUP 8-CYCLOHEXANONE CATALYST ETHYL CORPORATION (US) 1976-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12572075-B2 Composition, method of forming resist underlayer film, and method of forming resist pattern TOP1, NAF1, ASH2L ALDH1A1 2358/4885CYP1A2 2762/4885CYP3A4 2705/4885
US-20260098188-A1 RELEASE AGENT COMPOSITION FOR LIGHT IRRADIATION RELEASE, AND ADHESIVE COMPOSITION FOR LIGHT IRRADIATION RELEASE ERCC1, SMC2, SMC3 ALDH1A1 622/4885CYP1A2 539/4885CYP3A4 887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.